Sharon Moore, M.D., MBA, MPH

Chief Medical Officer

As chief medical officer, Dr. Sharon Wyatt Moore is responsible for strategic development and medical oversight of the clinical studies we conduct, and oversees the medical affairs, pharmacovigilance, strategic regulatory and medical writing teams.

Sharon brings 28 years of industry experience in medical, safety, QA, regulatory, and training to her role. She also has eight years of full-time clinical practice experience, where she was an investigator and IRB member and held a clinical appointment in the local medical school.

Prior to joining Clinipace, now Caidya, Sharon was chief medical and safety officer for a midsize CRO and was responsible for the global medical, pharmacovigilance, and medical writing departments. Sharon’s work has supported multiple therapeutic areas, and she continues to hold an active medical license. She has been a Certified Principal Investigator (APCR/ACRP) since 2004.

Sharon completed her M.D. degree at Vanderbilt University, US an MBA at East Tennessee State University, US and an MPH in general preventive medicine at the Medical College of Wisconsin, US.

Leading a new way

The latest from Caidya

Explore our news and updates as we deliver a superior customer experience.

03/13/2025

Caidya Strengthens Therapeutic Leadership: Names Adam Callahan Head of Oncology and Hematology

RALEIGH, N.C.; Mar. 13, 2025 – Caidya, a leading global,...

01/28/2025

Caidya Names Brandon Pallott as CCO to Drive Innovative Commercial Initiatives and Market Expansion

RALEIGH, N.C.; Jan. 28, 2025 – Caidya, a leading global,...

01/13/2025

Caidya Announces $165 Million Strategic Growth Investment from Rubicon Founders

RALEIGH, N.C.; Jan. 13, 2025 – Caidya, a leading global...
Skip to toolbar